Dynamic monitoring of HbA1c in Russian regions: data comparison of mobile medical center (Diamodul) and national diabetes register of Russian Federation

BACKGROUND: Glikogemoglobin (HbA1c) is a key clinical marker for evaluating the effectiveness of glucose-lowering therapy for patients with diabetes mellitus (DM) and the quality of diabetic care. AIMS: to conduct dynamic monitoring of the quality of glycemic control in DM patients based on a compr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Olga K. Vikulova, Anna V. Zheleznyakova, Mikhail А. Isakov, Alexey A. Serkov, Marina V. Shestakova, Ivan I. Dedov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2020
Materias:	diabetes mellitus mobile medical center diamodule glikogemoglobin (a1c) the register of diabetes mellitus Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/5f1cb90c62ca4c799a6a2882fc69883c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5f1cb90c62ca4c799a6a2882fc69883c
record_format	dspace
spelling	oai:doaj.org-article:5f1cb90c62ca4c799a6a2882fc69883c2021-11-14T09:00:23ZDynamic monitoring of HbA1c in Russian regions: data comparison of mobile medical center (Diamodul) and national diabetes register of Russian Federation2072-03512072-037810.14341/DM12327https://doaj.org/article/5f1cb90c62ca4c799a6a2882fc69883c2020-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/12327https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378BACKGROUND: Glikogemoglobin (HbA1c) is a key clinical marker for evaluating the effectiveness of glucose-lowering therapy for patients with diabetes mellitus (DM) and the quality of diabetic care. AIMS: to conduct dynamic monitoring of the quality of glycemic control in DM patients based on a comprehensive examination in mobile medical center (Diamodul) during repeated visits to the regions in 2019 compared with visits of Based Federal program “Diabetes Mellitus” (2005–2010) and data of the National diabetes register (NDR). MATERIALS AND METHODS: The object of the study: patients with T1DM and T2DM examined in Diamodul in 2019 in Voronezh region (Vr), Krasnodar region (Kr) (n = 600), there were “dynamic” group of re-examined (Vr n = 224; Kr n = 113), “random” group of new patients (Vr n = 72; Kr n = 191); group of adult patients from NDR with indicated HbA1c in 2019 (n = 2410067). RESULTS: According to Diamodul, the HbA1c levels are significantly worse than they were reported to NDR: the proportion of patients achieved HbA1c <7% for T1DM is 13.3% and 11.7%; T2DM – 25.1% and 28.6%, in Kr and Vr, respectively; in NDR: T1DM – 37.4%, T2DM – 52.2%. The average HbA1c values in the Diamodul are higher than in NDR by 0.95% for T1DM, 1.41% for T2DM patients. The proportion of patients with HbA1c≥9% decrease in dynamic of examinations through years in T1: in Vr from 53.1% in 2005 and 55.8% in 2010 to 42.9% in 2019, in Kr from 53.2% in 2006 to 43.8% in 2019; also there were decreases in the average HbA1c values in Vr from 9.3% in 2005 and 9.4% in 2010 to 8.8% in 2019; in Kr from 9.1% in 2006 to 8.7% in 2019. In T2DM patients with the best parameters of DM control in a whole, the positive trends were less pronounced and are assessed as non-deterioration: the proportion of HbA1c≥9 % in Vr: 34.7%–34.7%–36.4%, in Kr 40.1%–28.4%; average values of HbA1c: 8.2%–8.4%–8.5% and 8.6%–8.4%, respectively. CONCLUSIONS: The data of the research clearly indicates the need for 100% inclusion of HbA1c in the examination standards in all DM patients at the primary level at least 1 time per year, in order to monitor the real clinical situation, the effectiveness of glucose-lowering therapy and its timely intensification to prevent development of complications.Olga K. VikulovaAnna V. ZheleznyakovaMikhail А. IsakovAlexey A. SerkovMarina V. ShestakovaIvan I. DedovEndocrinology Research Centrearticlediabetes mellitusmobile medical centerdiamoduleglikogemoglobin (a1c)the register of diabetes mellitusNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 23, Iss 2, Pp 104-112 (2020)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus mobile medical center diamodule glikogemoglobin (a1c) the register of diabetes mellitus Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus mobile medical center diamodule glikogemoglobin (a1c) the register of diabetes mellitus Nutritional diseases. Deficiency diseases RC620-627 Olga K. Vikulova Anna V. Zheleznyakova Mikhail А. Isakov Alexey A. Serkov Marina V. Shestakova Ivan I. Dedov Dynamic monitoring of HbA1c in Russian regions: data comparison of mobile medical center (Diamodul) and national diabetes register of Russian Federation
description	BACKGROUND: Glikogemoglobin (HbA1c) is a key clinical marker for evaluating the effectiveness of glucose-lowering therapy for patients with diabetes mellitus (DM) and the quality of diabetic care. AIMS: to conduct dynamic monitoring of the quality of glycemic control in DM patients based on a comprehensive examination in mobile medical center (Diamodul) during repeated visits to the regions in 2019 compared with visits of Based Federal program “Diabetes Mellitus” (2005–2010) and data of the National diabetes register (NDR). MATERIALS AND METHODS: The object of the study: patients with T1DM and T2DM examined in Diamodul in 2019 in Voronezh region (Vr), Krasnodar region (Kr) (n = 600), there were “dynamic” group of re-examined (Vr n = 224; Kr n = 113), “random” group of new patients (Vr n = 72; Kr n = 191); group of adult patients from NDR with indicated HbA1c in 2019 (n = 2410067). RESULTS: According to Diamodul, the HbA1c levels are significantly worse than they were reported to NDR: the proportion of patients achieved HbA1c <7% for T1DM is 13.3% and 11.7%; T2DM – 25.1% and 28.6%, in Kr and Vr, respectively; in NDR: T1DM – 37.4%, T2DM – 52.2%. The average HbA1c values in the Diamodul are higher than in NDR by 0.95% for T1DM, 1.41% for T2DM patients. The proportion of patients with HbA1c≥9% decrease in dynamic of examinations through years in T1: in Vr from 53.1% in 2005 and 55.8% in 2010 to 42.9% in 2019, in Kr from 53.2% in 2006 to 43.8% in 2019; also there were decreases in the average HbA1c values in Vr from 9.3% in 2005 and 9.4% in 2010 to 8.8% in 2019; in Kr from 9.1% in 2006 to 8.7% in 2019. In T2DM patients with the best parameters of DM control in a whole, the positive trends were less pronounced and are assessed as non-deterioration: the proportion of HbA1c≥9 % in Vr: 34.7%–34.7%–36.4%, in Kr 40.1%–28.4%; average values of HbA1c: 8.2%–8.4%–8.5% and 8.6%–8.4%, respectively. CONCLUSIONS: The data of the research clearly indicates the need for 100% inclusion of HbA1c in the examination standards in all DM patients at the primary level at least 1 time per year, in order to monitor the real clinical situation, the effectiveness of glucose-lowering therapy and its timely intensification to prevent development of complications.
format	article
author	Olga K. Vikulova Anna V. Zheleznyakova Mikhail А. Isakov Alexey A. Serkov Marina V. Shestakova Ivan I. Dedov
author_facet	Olga K. Vikulova Anna V. Zheleznyakova Mikhail А. Isakov Alexey A. Serkov Marina V. Shestakova Ivan I. Dedov
author_sort	Olga K. Vikulova
title	Dynamic monitoring of HbA1c in Russian regions: data comparison of mobile medical center (Diamodul) and national diabetes register of Russian Federation
title_short	Dynamic monitoring of HbA1c in Russian regions: data comparison of mobile medical center (Diamodul) and national diabetes register of Russian Federation
title_full	Dynamic monitoring of HbA1c in Russian regions: data comparison of mobile medical center (Diamodul) and national diabetes register of Russian Federation
title_fullStr	Dynamic monitoring of HbA1c in Russian regions: data comparison of mobile medical center (Diamodul) and national diabetes register of Russian Federation
title_full_unstemmed	Dynamic monitoring of HbA1c in Russian regions: data comparison of mobile medical center (Diamodul) and national diabetes register of Russian Federation
title_sort	dynamic monitoring of hba1c in russian regions: data comparison of mobile medical center (diamodul) and national diabetes register of russian federation
publisher	Endocrinology Research Centre
publishDate	2020
url	https://doaj.org/article/5f1cb90c62ca4c799a6a2882fc69883c
work_keys_str_mv	AT olgakvikulova dynamicmonitoringofhba1cinrussianregionsdatacomparisonofmobilemedicalcenterdiamodulandnationaldiabetesregisterofrussianfederation AT annavzheleznyakova dynamicmonitoringofhba1cinrussianregionsdatacomparisonofmobilemedicalcenterdiamodulandnationaldiabetesregisterofrussianfederation AT mikhailaisakov dynamicmonitoringofhba1cinrussianregionsdatacomparisonofmobilemedicalcenterdiamodulandnationaldiabetesregisterofrussianfederation AT alexeyaserkov dynamicmonitoringofhba1cinrussianregionsdatacomparisonofmobilemedicalcenterdiamodulandnationaldiabetesregisterofrussianfederation AT marinavshestakova dynamicmonitoringofhba1cinrussianregionsdatacomparisonofmobilemedicalcenterdiamodulandnationaldiabetesregisterofrussianfederation AT ivanidedov dynamicmonitoringofhba1cinrussianregionsdatacomparisonofmobilemedicalcenterdiamodulandnationaldiabetesregisterofrussianfederation
_version_	1718429466370244608

Dynamic monitoring of HbA1c in Russian regions: data comparison of mobile medical center (Diamodul) and national diabetes register of Russian Federation

Ejemplares similares